$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"
쳇봇 이모티콘
안녕하세요!
ScienceON 챗봇입니다.
궁금한 것은 저에게 물어봐주세요.

논문 상세정보

Simplified HPLC Method for the Determination of Prazosin in Human Plasma and Its Application to Single-dose Pharmacokinetics

Abstract

Prazosin hydrochloride is an antihypertensive drug with selective ${\alpha}_1$-adrenoreceptor blocking effects. A simple high performance liquid chromatographic method has been developed and validated for the quantitative determination of prazosin in human plasma. A reversed-phase C18 column was used for the separation of prazosin and terazosin (internal standard) with a mobile phase composed of water, acetonitrile and triethylamine(75:25:0.1, V/V;pH5.0) at a flow rate of 1.5 ml/min. the fluorescence detector was set at excitation and emissionwavelengths of 250 and 370 nm, respectively. Intra-and inter-day precision and accuracy were acceptable for all quality control samples including the lower limit of quantification of 0.5 ng/ml. Good recovery (>80%) was seen in plasma. Prazosin was stable in human plasma under various storage conditions. This method was used successfully for a pharmacokinetic study in plasma after oral administration of a single 2-mg dose as prazosin base to 16 healthy volunteers. The maximum plasma concentration of prazosin was 23.1 ${\pm}$ 16.5 ng/ml at 2.1 h, and the mean area under the curve and elimination half-life were calculated to be 108.4 ${\pm}$ 74.2 ng ${\cdot}$hr/ml and 2.5 ${\pm}$ 0.6 h, respectively.

저자의 다른 논문

참고문헌 (13)

  1. Akduman, B. and Crawford, E. D. (2001). Terazosin, doxazosin and prazosin: current clinical experience. Urology 58, 49-54 
  2. Cho, E. S., Kang, S. H. and Chun, I. K. (2002). Determination of terazosin in human plasma by liquid chromatography and bioequivalence study of teratonin tablets. J Kor. Pharm. Sci. 32, 119-125 
  3. Constantine, J. W. (1975). Analysis of the hypotensive actions of prazosin. Postgrad. Med. Spec No, 18-35 
  4. Food and Drug Administration, Guidance for Industry: Bioanalytical method validation, Center for Drug Evaluation and Research, Rockville, MD, 2001 
  5. Hess, H. J. (1975). Prazosin: biochemistry and structure-activity studies with prazosin. Postgrad. Med. Spec No, 9-17 
  6. Hobbes, D. C., Twomey, T. M. and Palmer, R. F. (1978). Pharmacokinetics of prazosin in man. J Clin. Pharmacal. 18, 402-406 
  7. Kang, B. C., Yang, C. Q., Rhee, J. E., Suh, O. K. and Shin, W. G. (2001). High-performance liquid chromatographic analysis and pharmacokinetics of terazosin in healthy volunteers. Res. Cammun. Mal. Pathal. Pharmacal. 110, 371-377 
  8. Patterson, S. E. (1985). Terazosin kinetics after oral and intravenous doses. Clin. Pharmacal. Ther. 38, 423-427 
  9. Rathinavelu, A. and Malave, A. (1995). High-performance liquid chromatography using electrochemical detection for the determination of prazosin in biological samples. J Chromatogr. B. Biomed. Sci. Appl. 670, 177-182 
  10. Vincent, J., Meredith, P. A., Reid, J. L., Elliott, H. L. and Rubin, P. C. (1985). Clinical pharmacokinetics of prazosin. Clin. Pharmacokinet. 10. 144-154 
  11. Kamas, H. T., Shiu, G. and Shah, V. P. (1991). Validation of bioanalytical methods. Pharm. Res. 8, 421-426 
  12. Sekhar, B. C., Rao, T. R., Sekhar, K. R., Naidu, M. U., Shobha, J. C., Rani, P. U., Kumar, T. V. and Kumar, V. P. (1998). Determination of terazosin in human plasma, using high-performance liquid chromatography with fluorescence detection. J Chromatogr. B. Biomed. Sci. Appl. 710, 137-142 
  13. Cheah, P. Y., Yuen, K. H. and Liong, M. L. (2000). Improved high-performance liquid chromatographic analysis of terazosin in human plasma. J Chromatogr. B. Biomed. Sci. Appl. 745, 439-443 

이 논문을 인용한 문헌 (0)

  1. 이 논문을 인용한 문헌 없음

원문보기

원문 PDF 다운로드

  • ScienceON :

원문 URL 링크

원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다. (원문복사서비스 안내 바로 가기)

상세조회 0건 원문조회 0건

DOI 인용 스타일